Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

2024_WIREsNanNano_Nanomedicine_TorrentsE.pdf (9.01 MB)

Tipus de document

Altres

Versió

Versió publicada

Data de publicació

2024-02-25

Llicència de publicació

cc by-nc-nd (c) Blanco Cabra, Núria et al, 2024
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/211263

Nanomedicine against biofilm infections: A roadmap of challenges and limitations

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/wnan.1944

Resum

Microbial biofilms are complex three-dimensional structures where sessile microbes are embedded in a polymeric extracellular matrix. Their resistance toward the host immune system as well as to a diverse range of antimicrobial treatments poses a serious health and development threat, being in the top 10 global public health threats declared by the World Health Organization. In an effort to combat biofilm-related microbial infections, several strategies have been developed to independently eliminate biofilms or to complement conventional antibiotic therapies. However, their limitations leave room for other treatment alternatives, where the application of nanotechnology to biofilm eradication has gained significant relevance in recent years. Their small size, penetration efficiency, and the design flexibility that they present makes them a promising alternative for biofilm infection treatment, although they also present set-backs. This review aims to describe the main possibilities and limitations of nanomedicine against biofilms, while covering the main aspects of biofilm formation and study, and the current therapies for biofilm treatment. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine.

Matèries

Nanomedicina, Polímers, Terapèutica

Matèries (anglès)

Nanomedicine, Polymers, Therapeutics

Citació

Col·leccions

Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Citació

BLANCO-CABRA, Núria, et al. Nanomedicine against biofilm infections: A roadmap of challenges and limitations. Wiley Interdisciplinary Reviews-Nanomedicine And Nanobiotechnology. 2024. Vol. 16, num. 1. ISSN 1939-0041. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/211263

Exportar metadades

JSON - METS

Compartir registre